Why Trump Can Boost Biotech ETFs

Related: Healthcare ETFs Ready to Rally

The impact of a Trump presidency on healthcare stocks remains to be seen. Candidate Trump rebuked Obamacare and if successful in that effort, there would likely be some effect on diversified healthcare ETFs due to their exposure to health insurance providers.

“However, as we continue to watch Mr. Trump’s healthcare plan develop, we caution that healthcare/pricing could be one of the areas where Mr. Trump makes concessions with Democrats,” adds Credit Suisse.

For more information on the biotech sector, visit our biotechnology category.

iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB)